欧洲实体瘤软脑膜转移患者的诊断与治疗模式
该调查于2016年4月7日至2016年8月8日面向欧洲神经肿瘤学会和欧洲癌症研究与治疗组织脑肿瘤组成员发放网络问卷,含25道最佳实践选择题和8个病例情景。224名来自26个国家的同行启动调查,115人完成全部问卷。结果显示,欧洲实体瘤软脑膜转移的诊断与治疗决策差异很大,脑脊液流动研究、鞘内化疗和放疗的使用存在明显不同,病例情景中的决策差异更大。
要点
- 实体瘤软脑膜转移影响高达10%的实体瘤患者,1年总生存率仅约10%。
- 欧洲26个国家224名同行参与调查,115人完成全部问卷。
- 诊断与治疗决策在欧洲各地差异很大,需标准化诊断评估工具和对照研究提高证据水平。
核心结论
- 欧洲实体瘤软脑膜转移的诊断与治疗决策差异很大,需要标准化诊断和评估工具以及对照研究来提高所有治疗方法的证据水平。
研究设计与样本
- 网络问卷调查,包含25道最佳实践简单或多选题和8个病例情景,于2016年4月7日至2016年8月8日发放给欧洲神经肿瘤学会和欧洲癌症研究与治疗组织脑肿瘤组成员。
- 224名来自26个国家的同行启动调查,115名完成全部问卷。
主要发现
- 在诊断和治疗的总体方法上存在重大差异,例如脑脊液流动研究、鞘内化疗和各类放疗的使用。
- 在单个病例情景中选择诊断和治疗措施时差异更大。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Leptomeningeal metastases are a late manifestation of systemic cancer which affects up to 10% of patients with solid tumors. Prognosis is poor, and overall survival at 1 year is only approximately 10%. Management depends mainly on general and neurological condition, primary tumor, and patterns of metastasis, notably absence or presence of concurrent systemic or solid brain metastases. Here we set out to characterize current practice patterns of diagnosis and treatment of patients with leptomeningeal metastasis in Europe. We prepared a web-based survey including 25 simple or multiple choices questions on best practice supplemented by eight case vignettes with various diagnosis and management options. The survey was sent to the membership of the European Association of Neuro-Oncology and the European Organisation for Research and Treatment of Cancer Brain Tumor Group. Between April 7, 2016 and August 8, 2016, 224 colleagues from 26 countries initiated the survey, 115 colleagues completed the whole survey. There were major differences both in the general diagnostic and therapeutic approach, e.g., regarding the use of cerebrospinal fluid (CSF) flow studies, intra-CSF chemotherapy, various types of radiotherapy, and even more so when selecting decisions on diagnostic and therapeutic measures for single case vignettes. Diagnosis and treatment decisions for patients with leptomeningeal metastasis from solid tumors vary widely across Europe. Standardization of diagnosis and evaluation tools as well as controlled studies to improve the level of evidence for all therapeutic approaches to LM are required.
引用
- Le Rhun E, Rudà R, Devos P, et al. Diagnosis and treatment patterns for patients with leptomeningeal metastasis from solid tumors across Europe. J Neurooncol. 2017. PMID: 28455788. doi:10.1007/s11060-017-2452-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。